HMS
CYTK icon

Hanseatic Management Services’s Cytokinetics CYTK Stock Holding History

Hanseatic Management Services’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-192
Closed -$2K – 238
2019
Q3 		$2K Buy
+192
New +$2.41K ﹤0.01% 187

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hanseatic Management Services's CYTK Position: Q4 2019 in Review

Hanseatic Management Services sold out of Cytokinetics (CYTK) in Q4 2019, closing a stake of 192 shares — an estimated $2K sold.

Hanseatic Management Services first reported a position in CYTK in Q3 2019 and held it in 1 quarter. The position peaked at $2K in Q3 2019. 142 funds tracked by Wall St. Rank hold CYTK as of Q4 2019.

  • Hanseatic Management Services reported no remaining Cytokinetics position as of Q4 2019 after selling out during the quarter.
  • Hanseatic Management Services sold 192 Cytokinetics shares in Q4 2019, an estimated $2K.
  • Hanseatic Management Services first reported a position in Cytokinetics in Q3 2019 and held it in 1 quarter.
  • Hanseatic Management Services's Cytokinetics position peaked at $2K in Q3 2019.
  • 142 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2019.

Based on Hanseatic Management Services's 13F filing for Q4 2019, filed 29 Jan 2020.